ProRx Pharma, the leading health and wellness 503B outsourcing facility, today announced the commercial availability of its oral testosterone, a first-of-its-kind formulation that delivers the therapeutic effect of injectables without the burden of needles.
Designed to provide a more practical and manageable therapy option, ProRx’s new oral testosterone enables telemedicine, med spa, and clinic-based providers to expand hormone-replacement services safely and at scale. Healthcare providers no longer need to manage injectable protocols, which require in-person patient visits and higher clinical oversight along with increased risks associated with the sterility of the procedures. Read More >
